These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25490425)

  • 1. Strategies to antagonize miRNA functions in vitro and in vivo.
    Baigude H; Rana TM
    Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
    Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
    Kaucsár T; Rácz Z; Hamar P
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing microRNA by interfering nanoparticles in mice.
    Su J; Baigude H; McCarroll J; Rana TM
    Nucleic Acids Res; 2011 Mar; 39(6):e38. PubMed ID: 21212128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microRNA with antisense oligonucleotides.
    Esau CC
    Methods; 2008 Jan; 44(1):55-60. PubMed ID: 18158133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential for microRNAs.
    Esau CC; Monia BP
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):101-14. PubMed ID: 17462786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as targets for antisense-based therapeutics.
    Stenvang J; Kauppinen S
    Expert Opin Biol Ther; 2008 Jan; 8(1):59-81. PubMed ID: 18081537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification and design of anti-miRNA oligonucleotides.
    Lennox KA; Behlke MA
    Gene Ther; 2011 Dec; 18(12):1111-20. PubMed ID: 21753793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA silencing in primates: towards development of novel therapeutics.
    Petri A; Lindow M; Kauppinen S
    Cancer Res; 2009 Jan; 69(2):393-5. PubMed ID: 19147547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An LNA-based loss-of-function assay for micro-RNAs.
    Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A
    Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles.
    Liu XQ; Song WJ; Sun TM; Zhang PZ; Wang J
    Mol Pharm; 2011 Feb; 8(1):250-9. PubMed ID: 21138272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleotide Modification of Anti-miRNA Oligonucleotides.
    Lennox KA; Vakulskas CA; Behlke MA
    Methods Mol Biol; 2017; 1517():51-69. PubMed ID: 27924473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
    Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
    Oh SY; Ju Y; Kim S; Park H
    Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved targeting of miRNA with antisense oligonucleotides.
    Davis S; Lollo B; Freier S; Esau C
    Nucleic Acids Res; 2006; 34(8):2294-304. PubMed ID: 16690972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonconventional chemical inhibitors of microRNA: therapeutic scope.
    Jayaraj GG; Nahar S; Maiti S
    Chem Commun (Camb); 2015 Jan; 51(5):820-31. PubMed ID: 25328158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.